Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05871151 · ClinicalTrials.gov registry record · NA

Combining VNS With PT Interventions for Individuals With PD

A NA study of Parkinson Disease, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
25
Enrollment target
2
Study locations

NCT05871151 is a NA study of Parkinson Disease that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 25 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05871151, a NA study of Parkinson Disease, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate the combined effects of non-invasive neuromodulation (specifically transauricular Vagus Nerve Stimulation) with exercise interventions to improve physical function and quality of life in individuals with Parkinsons Disease.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise
  • DEVICE taVNS

Study Locations (2)

Alabama

  • WHARF - Birmingham
  • UAB - Birmingham

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2023-10-01
Est. Completion 2024-12-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05871151

The ClinicalTrials.gov registry entry for NCT05871151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT05871151 reports 2 study locations spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05871151 about?

NCT05871151 is a clinical study titled "Combining VNS With PT Interventions for Individuals With PD". The purpose of this study is to evaluate the combined effects of non-invasive neuromodulation (specifically transauricular Vagus Nerve Stimulation) with exercise interventions to improve physical function and quality of life in individuals with Parkinsons Disease.

What is the current status of trial NCT05871151?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2023-10-01. Estimated completion is 2024-12-01.

What conditions does trial NCT05871151 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05871151?

The interventions under investigation include: Exercise (BEHAVIORAL), taVNS (DEVICE).

Who is sponsoring clinical trial NCT05871151?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05871151 being conducted?

This trial has 2 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.